Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Tontini

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
ACS Chemical Biology|February 27, 2018
Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine AntigensDavide Oldrini, Timm Fiebig, Maria Rosaria Romano, et al.
Glycoconjugate Journal|September 27, 2014
Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal diseaseRoberto Adamo, Alberto Nilo, Carole Harfouche, et al.
Carbohydrate Polymers|April 19, 2026
Immune responses to glycoconjugate vaccines rely on a balance between polysaccharide length and glycosylation densityFilippo Carboni, Nicoletta Bechi, Daniela Proietti, et al.
Scientific Reports|July 22, 2016
Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccinesCecilia Buonsanti, Cristiana Balocchi, Carole Harfouche, et al.
ACS Chemical Biology|May 25, 2012
Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharideRoberto Adamo, Maria R Romano, Francesco Berti, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup XFrancesca Micoli, Maria Rosaria Romano, Marta Tontini, et al.
Nature Communications|November 26, 2020
Publisher Correction: A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup AJacopo Enotarpi, Marta Tontini, Cristiana Balocchi, et al.
Nature Communications|September 8, 2020
A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup AJacopo Enotarpi, Marta Tontini, Cristiana Balocchi, et al.
Frontiers in Molecular Biosciences|November 1, 2021
Elucidating the Structural and Minimal Protective Epitope of the Serogroup X Meningococcal Capsular PolysaccharideGian Pietro Pietri, Marta Tontini, Barbara Brogioni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humansDavide Serruto, Tiziana Spadafina, Laura Ciucchi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
ACS Chemical Biology|February 27, 2018
Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine AntigensDavide Oldrini, Timm Fiebig, Maria Rosaria Romano, et al.
Glycoconjugate Journal|September 27, 2014
Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal diseaseRoberto Adamo, Alberto Nilo, Carole Harfouche, et al.
Carbohydrate Polymers|April 19, 2026
Immune responses to glycoconjugate vaccines rely on a balance between polysaccharide length and glycosylation densityFilippo Carboni, Nicoletta Bechi, Daniela Proietti, et al.
Scientific Reports|July 22, 2016
Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccinesCecilia Buonsanti, Cristiana Balocchi, Carole Harfouche, et al.
ACS Chemical Biology|May 25, 2012
Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharideRoberto Adamo, Maria R Romano, Francesco Berti, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup XFrancesca Micoli, Maria Rosaria Romano, Marta Tontini, et al.
Nature Communications|November 26, 2020
Publisher Correction: A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup AJacopo Enotarpi, Marta Tontini, Cristiana Balocchi, et al.
Nature Communications|September 8, 2020
A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup AJacopo Enotarpi, Marta Tontini, Cristiana Balocchi, et al.
Frontiers in Molecular Biosciences|November 1, 2021
Elucidating the Structural and Minimal Protective Epitope of the Serogroup X Meningococcal Capsular PolysaccharideGian Pietro Pietri, Marta Tontini, Barbara Brogioni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humansDavide Serruto, Tiziana Spadafina, Laura Ciucchi, et al.
Pageof 3